Discussion by rheumatologists on the merits of biologics vs. triple therapy for patients with RA lends insight into therapeutic alternatives
2013 ACR/ARHP Annual Meeting: Rheumatology Year in Review
Progress in treatments for pediatric rheumatic diseases, collaborative clinical trials, and personalized therapeutic approaches highlight the past year in rheumatology
2013 ACR/ARHP Annual Meeting: Advances in Genomic Research Demystify, Defeat Disease
Researcher J. Craig Venter, PhD, explains how technological progress in metabiomics may enable scientists to create synthetic, engineered bacteria to counter diseases and manufacture virus-fighting vaccines where they are needed
EULAR 2013: New RA Recommendations Address Combination Therapy Concerns
Guidelines give greater nod to use of combination conventional disease-modifying antirheumatic drugs (DMARDs) for rheumatoid arthritis, leave monotherapy with methotrexate as acceptable first-line treatment
My Experience at the ACR Dallas Rheumatology Research Workshop
A second-year rheumatology fellow reflects on lectures and lessons learned at the event
EULAR 2013: Researchers Expand Targets for PsA, OA Therapy
Experts discuss insights in the pathogenesis of psoriatic arthritis and the role of subchondral bone in osteoarthritis
EULAR 2013: Drugs New and Old Could Treat Spondylarthropies
Nonsteroidal anti-inflammatory drugs (NSAIDs) might still have a role in treating axial spondylarthritis, but other drugs, therapies are being explored
EULAR 2013: Researchers Make Inroads in Treatment of Osteoarthritis
Experts discuss evidence-based benefits of knee joint distraction and the progress being made in harnessing the effects of stem cells
EULAR 2013: Tips for Managing Peripheral Neuropathy in Rheumatic Disease
How to determine which tests to order, how to interpret them, and how to decide on the right treatment course
EULAR 2013: Emerging Imaging Methods in Spondylarthritis Have Advantages and Flaws
New technologies from diffusion-weighted imaging to ultrasonography are being studied and refined, but much is yet to be understood
- « Previous Page
- 1
- …
- 83
- 84
- 85
- 86
- 87
- …
- 98
- Next Page »